Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single-nucleus multiomics unveils malignant cellular states, regulatory architectures and microenvironmental reorganization across the G-CIMP epigenomic transition in IDH-mutant glioma.

bioRxiv : the preprint server for biology·2026
Same author

Iterative immunoprecipitation and phage pre-wash dramatically improve epitope-resolved serology by VirScan.

Frontiers in virology (Lausanne, Switzerland)·2026
Same author

Understanding Older Korean Americans' Experiences with the MoCA-K: A Qualitative Study.

Clinical gerontologist·2026
Same author

Temporalis Muscle Thickness as a Prognostic Factor for 30-Day, 90-Day, and Overall Mortality in Newly Diagnosed Glioblastoma.

Cureus·2026
Same author

Local control and leptomeningeal disease after resection and GammaTile brachytherapy for newly diagnosed brain metastases: results from a prospective registry.

Journal of neuro-oncology·2026
Same author

Exploring medication adherence in racial/ethnic minorities.

Frontiers in pharmacology·2026

Related Experiment Video

Updated: Feb 28, 2026

Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations
04:46

Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations

Published on: February 24, 2023

2.4K

Reoperation for Recurrent Glioblastoma Multiforme.

Adam M Robin1, Ian Lee2, Steven N Kalkanis2

  • 1Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.

Neurosurgery Clinics of North America
|June 11, 2017
PubMed
Summary

Reoperation for recurrent glioblastoma multiforme (GBM) remains controversial. While some studies suggest improved survival and quality of life, evidence for a survival benefit is not definitive.

Keywords:
Extent of resectionGlioblastoma multiformeRecurrenceReoperationResectionSurvival

More Related Videos

Image-Guided Resection of Glioblastoma and Intracranial Implantation of Therapeutic Stem Cell-seeded Scaffolds
09:18

Image-Guided Resection of Glioblastoma and Intracranial Implantation of Therapeutic Stem Cell-seeded Scaffolds

Published on: July 16, 2018

8.8K
Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

27.9K

Related Experiment Videos

Last Updated: Feb 28, 2026

Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations
04:46

Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations

Published on: February 24, 2023

2.4K
Image-Guided Resection of Glioblastoma and Intracranial Implantation of Therapeutic Stem Cell-seeded Scaffolds
09:18

Image-Guided Resection of Glioblastoma and Intracranial Implantation of Therapeutic Stem Cell-seeded Scaffolds

Published on: July 16, 2018

8.8K
Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

27.9K

Area of Science:

  • Neuro-oncology
  • Neurosurgery
  • Clinical Neurology

Background:

  • Glioblastoma multiforme (GBM) is an aggressive brain tumor with a high recurrence rate.
  • The optimal management strategy for recurrent GBM is not well-established.
  • Reoperation is a potential treatment option, but its efficacy is debated.

Purpose of the Study:

  • To comprehensively review the current literature on the role of reoperation for recurrent glioblastoma multiforme.
  • To evaluate the evidence regarding survival and quality of life outcomes following repeat surgery for GBM.
  • To address the controversial question of whether to pursue surgical intervention for progressive or recurrent GBM.

Main Methods:

  • Systematic literature review of studies investigating reoperation for recurrent glioblastoma multiforme.
  • Analysis of factors influencing prognosis, including patient age, functional status, and surgical details.
  • Evaluation of data on survival benefits and quality of life improvements associated with repeat operations.

Main Results:

  • Evidence suggests potential improvements in survival and quality of life with reoperation for recurrent GBM in some patient cohorts.
  • Prognosis is influenced by multiple factors such as age, functional status, initial resection extent, tumor location, and surgical success.
  • Conversely, significant data also indicates no clear survival advantage for reoperation in recurrent GBM patients.

Conclusions:

  • The role of reoperation for recurrent glioblastoma multiforme is controversial and lacks definitive consensus.
  • Patient selection is critical, considering individual prognostic factors to guide treatment decisions.
  • Further research is needed to clarify the benefits and risks of repeat surgery for recurrent GBM.